-
1
-
-
0034817278
-
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: The 15-year Johns Hopkins experience
-
DOI 10.1016/S0094-0143(05)70163-4
-
M. Han, A. Partin, and C. Pound Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: The 15-year Johns Hopkins experience Urol Clin North Am 28 2001 555 565 (Pubitemid 32916759)
-
(2001)
Urologic Clinics of North America
, vol.28
, Issue.3
, pp. 555-565
-
-
Han, M.1
Partin, A.W.2
Pound, C.R.3
Epstein, J.I.4
Walsh, P.C.5
-
2
-
-
0033526309
-
Natural history of progression after PSA elevation following radical prostatectomy
-
DOI 10.1001/jama.281.17.1591
-
C. Pound, A. Partin, and M. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597 (Pubitemid 29211767)
-
(1999)
Journal of the American Medical Association
, vol.281
, Issue.17
, pp. 1591-1597
-
-
Pound, C.R.1
Partin, A.W.2
Eisenberger, M.A.3
Chan, D.W.4
Pearson, J.D.5
Walsh, P.C.6
-
3
-
-
0033787042
-
Prognostic significance of Gleason score 3+ 4 versus Gleason score 4+ 3 tumor at radical prostatectomy
-
T. Chan, A. Partin, and P. Walsh Prognostic significance of Gleason score 3+ 4 versus Gleason score 4+ 3 tumor at radical prostatectomy Urology 56 2000 823 827
-
(2000)
Urology
, vol.56
, pp. 823-827
-
-
Chan, T.1
Partin, A.2
Walsh, P.3
-
4
-
-
0030025610
-
Prediction of progression following radical prostatectomy: A multivariate analysis of 721 men with long-term follow-up
-
DOI 10.1097/00000478-199603000-00004
-
J. Epstein, A. Partin, and J. Sauvageot Prediction of progression following radical prostatectomy: A multivariate analysis of 721 men with long-term follow-up Am J Surg Pathol 20 1996 286 292 (Pubitemid 26071509)
-
(1996)
American Journal of Surgical Pathology
, vol.20
, Issue.3
, pp. 286-292
-
-
Epstein, J.I.1
Partin, A.W.2
Sauvageot, J.3
Walsh, P.C.4
-
5
-
-
0142186677
-
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era
-
DOI 10.1016/S0360-3016(03)00632-1
-
D. Kuban, H. Thames, and L. Levy Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era Int J Radiat Oncol Biol Phys 57 2003 915 928 (Pubitemid 37324109)
-
(2003)
International Journal of Radiation Oncology Biology Physics
, vol.57
, Issue.4
, pp. 915-928
-
-
Kuban, D.A.1
Thames, H.D.2
Levy, L.B.3
Horwitz, E.M.4
Kupelian, P.A.5
Martinez, A.A.6
Michalski, J.M.7
Pisansky, T.M.8
Sandler, H.M.9
Shipley, W.U.10
Zelefsky, M.J.11
Zietman, A.L.12
-
6
-
-
0034268588
-
External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era
-
A. Pollack, L. Smith, and A. von Eschenbach External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era Int J Radiat Oncol Biol Phys 48 2000 507 512
-
(2000)
Int J Radiat Oncol Biol Phys
, vol.48
, pp. 507-512
-
-
Pollack, A.1
Smith, L.2
Von Eschenbach, A.3
-
7
-
-
0031022948
-
A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma
-
DOI 10.1002/(SICI)1097-0142(19970115)79:2<337::AID-CNCR17>3.0.CO;2- 1
-
T. Pisansky, M. Kahn, and G. Rasp A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma Cancer 79 1997 337 344 (Pubitemid 27029898)
-
(1997)
Cancer
, vol.79
, Issue.2
, pp. 337-344
-
-
Pisansky, T.M.1
Kahn, M.J.2
Rasp, G.M.3
Cha, S.S.4
Haddock, M.G.5
Bostwick, D.G.6
-
8
-
-
77649158894
-
National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Prostate Cancer
-
J. Mohler, R. Bahnson, and B. Boston National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Prostate Cancer J Natl Compr Canc Neww 8 2010 162 200
-
(2010)
J Natl Compr Canc Neww
, vol.8
, pp. 162-200
-
-
Mohler, J.1
Bahnson, R.2
Boston, B.3
-
9
-
-
67651122848
-
Gleason pattern 5 prostate cancer: Further stratification of patients with high-risk disease and implications for future randomized trials
-
A. Nanda, M. Chen, and A. Renshaw Gleason pattern 5 prostate cancer: Further stratification of patients with high-risk disease and implications for future randomized trials Int J Radiat Oncol Biol Phys 74 2009 1419 1423
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.74
, pp. 1419-1423
-
-
Nanda, A.1
Chen, M.2
Renshaw, A.3
-
10
-
-
70449334526
-
Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy
-
R. Stock, J. Cesaretti, and S. Hall Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy BJU Int 104 2009 1631 1636
-
(2009)
BJU Int
, vol.104
, pp. 1631-1636
-
-
Stock, R.1
Cesaretti, J.2
Hall, S.3
-
11
-
-
35648964767
-
Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy
-
DOI 10.1002/cncr.23004
-
L. Cheng, D. Davidson, and H. Lin Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy Cancer 110 2007 1967 1972 (Pubitemid 350036855)
-
(2007)
Cancer
, vol.110
, Issue.9
, pp. 1967-1972
-
-
Cheng, L.1
Davidson, D.D.2
Lin, H.3
Koch, M.O.4
-
12
-
-
19444364960
-
The combined percentage of gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy
-
DOI 10.1200/JCO.2005.03.018
-
L. Cheng, M. Koch, and B. Juliar The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy J Clin Oncol 23 2005 2911 2917 (Pubitemid 46224109)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.13
, pp. 2911-2917
-
-
Cheng, L.1
Koch, M.O.2
Juliar, B.E.3
Daggy, J.K.4
Foster, R.S.5
Bihrle, R.6
Gardner, T.A.7
-
13
-
-
33847302011
-
The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer
-
D. D'Ambrosio, A. Hanlon, and T. Al-Saleem The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 67 2007 1082 1087
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.67
, pp. 1082-1087
-
-
D'Ambrosio, D.1
Hanlon, A.2
Al-Saleem, T.3
-
14
-
-
0033591010
-
Biological determinants of cancer progression in men with prostate cancer
-
DOI 10.1001/jama.281.15.1395
-
T. Stamey, J. McNeal, and C. Yemoto Biological determinants of cancer progression in men with prostate cancer JAMA 281 1999 1395 1400 (Pubitemid 29190217)
-
(1999)
Journal of the American Medical Association
, vol.281
, Issue.15
, pp. 1395-1400
-
-
Stamey, T.A.1
McNeal, J.E.2
Yemoto, C.M.3
Sigal, B.M.4
Johnstone, I.M.5
-
15
-
-
33847148917
-
Should We Replace the Gleason Score with the Amount of High-Grade Prostate Cancer?
-
DOI 10.1016/j.eururo.2006.07.051, PII S0302283806008918
-
A. Vis, S. Roemeling, and R. Kranse Should we replace the Gleason score with the amount of high-grade prostate cancer? Eur Urol 51 2007 931 939 (Pubitemid 46281411)
-
(2007)
European Urology
, vol.51
, Issue.4
, pp. 931-939
-
-
Vis, A.N.1
Roemeling, S.2
Kranse, R.3
Schroder, F.H.4
Van Der Kwast, T.H.5
-
16
-
-
79952701542
-
Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer: Who dies of disease?
-
In press
-
Kuban D, Levy L, Cheung M, et al. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer: Who dies of disease? Int J Radiat Oncol Biol Phys. In press.
-
Int J Radiat Oncol Biol Phys
-
-
Kuban, D.1
Levy, L.2
Cheung, M.3
-
17
-
-
0042383094
-
Dose escalation for localized prostate cancer: Substantial benefit observed with 3D conformal therapy
-
DOI 10.1016/S0360-3016(03)00569-8
-
Z. Symon, K. Griffith, and P. McLaughlin Dose escalation for localized prostate cancer: Substantial benefit observed with 3D conformal therapy Int J Radiat Oncol Biol Phys 57 2003 384 390 (Pubitemid 37040934)
-
(2003)
International Journal of Radiation Oncology Biology Physics
, vol.57
, Issue.2
, pp. 384-390
-
-
Symon, Z.1
Griffith, K.A.2
McLaughlin, P.W.3
Sullivan, M.4
Sandler, H.M.5
-
18
-
-
33745184874
-
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
-
M. Roach 3rd, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 965-974
-
-
Roach III, M.1
Hanks, G.2
Thames Jr., H.3
-
19
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
-
DOI 10.1016/0021-9681(87)90171-8
-
M.E. Charlson, P. Pompei, and K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation J Chronic Dis 40 1987 373 383 (Pubitemid 17055592)
-
(1987)
Journal of Chronic Diseases
, vol.40
, Issue.5
, pp. 373-383
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.A.3
MacKenzie, C.R.4
-
20
-
-
77950968988
-
Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death
-
T.K. Choueiri, M.H. Chen, and A.V. D'Amico Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death Cancer 116 2010 1887 1892
-
(2010)
Cancer
, vol.116
, pp. 1887-1892
-
-
Choueiri, T.K.1
Chen, M.H.2
D'Amico, A.V.3
-
21
-
-
37049031020
-
Interval to Biochemical Failure Highly Prognostic for Distant Metastasis and Prostate Cancer-Specific Mortality After Radiotherapy
-
DOI 10.1016/j.ijrobp.2007.05.047, PII S0360301607009777
-
M.K. Buyyounouski, A.L. Hanlon, and E.M. Horwitz Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapy Int J Radiat Oncol Biol Phys 70 2008 59 66 (Pubitemid 350251025)
-
(2008)
International Journal of Radiation Oncology Biology Physics
, vol.70
, Issue.1
, pp. 59-66
-
-
Buyyounouski, M.K.1
Hanlon, A.L.2
Horwitz, E.M.3
Pollack, A.4
-
22
-
-
70449708045
-
Measuring time to biochemical failure in the TROG 96.01 trial: When should the clock start ticking?
-
J.W. Denham, A. Steigler, and M. Kumar Measuring time to biochemical failure in the TROG 96.01 trial: When should the clock start ticking? Int J Radiat Oncol Biol Phys 75 2009 1008 1012
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.75
, pp. 1008-1012
-
-
Denham, J.W.1
Steigler, A.2
Kumar, M.3
-
23
-
-
54349113978
-
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: Evidence from the TROG 96.01 randomised controlled trial
-
J.W. Denham, A. Steigler, and C. Wilcox Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial Lancet Oncol 9 2008 1058 1068
-
(2008)
Lancet Oncol
, vol.9
, pp. 1058-1068
-
-
Denham, J.W.1
Steigler, A.2
Wilcox, C.3
-
24
-
-
24144493035
-
The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma
-
DOI 10.1097/01.pas.0000173646.99337.b1
-
J. Epstein, W. Allsbrook Jr., and M. Amin The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma Am J Surg Pathol 29 2005 1228 1242 (Pubitemid 41232997)
-
(2005)
American Journal of Surgical Pathology
, vol.29
, Issue.9
, pp. 1228-1242
-
-
Epstein, J.I.1
Allsbrook Jr., W.C.2
Amin, M.B.3
Egevad, L.L.4
Bastacky, S.5
Lopez Beltran, A.6
Berner, A.7
Billis, A.8
Boccon-Gibod, L.9
Cheng, L.10
Civantos, F.11
Cohen, C.12
Cohen, M.B.13
Datta, M.14
Davis, C.15
Delahunt, B.16
Delprado, W.17
Eble, J.N.18
Foster, C.S.19
Furusato, M.20
Gaudin, P.B.21
Grignon, D.J.22
Humphrey, P.A.23
Iczkowski, K.A.24
Jones, E.C.25
Lucia, S.26
McCue, P.A.27
Nazeer, T.28
Oliva, E.29
Pan, C.-C.30
Pizov, G.31
Reuter, V.32
Samaratunga, H.33
Sebo, T.34
Sesterhenn, I.35
Shevchuk, M.36
Srigley, J.R.37
Suzigan, S.38
Takahashi, H.39
Tamboli, P.40
Tan, P.H.41
Tetu, B.42
Tickoo, S.43
Tomaszewski, J.E.44
Troncoso, P.45
Tsuzuki, T.46
True, L.D.47
Van Der Kwast, T.48
Wheeler, T.M.49
Wojno, K.J.50
Young, R.H.51
more..
-
25
-
-
59649091159
-
Predicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factors
-
P.L. Nguyen, M.H. Chen, and W.J. Catalona Predicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factors Intt J Radiat Oncol Biol Phys 73 2009 659 664
-
(2009)
Intt J Radiat Oncol Biol Phys
, vol.73
, pp. 659-664
-
-
Nguyen, P.L.1
Chen, M.H.2
Catalona, W.J.3
-
26
-
-
58149327450
-
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy
-
N. Stone, L. Potters, and B. Davis Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 73 2009 341 346
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.73
, pp. 341-346
-
-
Stone, N.1
Potters, L.2
Davis, B.3
-
27
-
-
1642576015
-
The Relationship of Increasing Radiotherapy Dose to Reduced Distant Metastases and Mortality in Men with Prostate Cancer
-
DOI 10.1002/cncr.11927
-
R. Jacob, A.L. Hanlon, and E.M. Horwitz The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer Cancer 100 2004 538 543 (Pubitemid 38124771)
-
(2004)
Cancer
, vol.100
, Issue.3
, pp. 538-543
-
-
Jacob, R.1
Hanlon, A.L.2
Horwitz, E.M.3
Movsas, B.4
Uzzo, R.G.5
Pollack, A.6
-
29
-
-
34250862630
-
Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy
-
DOI 10.1002/cncr.22755
-
P.B. Morgan, A.L. Hanlon, and E.M. Horwitz Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy Cancer 110 2007 68 80 (Pubitemid 46986420)
-
(2007)
Cancer
, vol.110
, Issue.1
, pp. 68-80
-
-
Morgan, P.B.1
Hanlon, A.L.2
Horwitz, E.M.3
Buyyounouski, M.K.4
Uzzo, R.G.5
Pollack, A.6
-
30
-
-
60049090809
-
Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival: Results from a Canadian randomized trial
-
J.M. Crook, S. Malone, and G. Perry Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival: Results from a Canadian randomized trial Cancer 115 2009 673 679
-
(2009)
Cancer
, vol.115
, pp. 673-679
-
-
Crook, J.M.1
Malone, S.2
Perry, G.3
-
31
-
-
0036662309
-
Gleason score predicts androgen independent progression after androgen deprivation therapy
-
DOI 10.1016/S0302-2838(02)00238-5, PII S0302283802002385
-
E. Benaim, C. Pace, and C. Roehrborn Gleason score predicts androgen independent progression after androgen deprivation therapy Eur Urol 42 2002 12 17 (Pubitemid 35339640)
-
(2002)
European Urology
, vol.42
, Issue.1
, pp. 12-17
-
-
Benaim, E.A.1
Pace, C.M.2
Roehrborn, C.G.3
-
32
-
-
80255124425
-
A phase III protocol of androgen suppression (AS) and radiation therapy (RT) versus AS and RT followed by chemotherapy with paclitaxel, extramustine, and etoposide (TEE) for localized, high-risk, prostate cancer, RTOG 9902
-
Chicago, IL
-
Sandler HM, Hunt D, Sartor AO, et al. A phase III protocol of androgen suppression (AS) and radiation therapy (RT) versus AS and RT followed by chemotherapy with paclitaxel, extramustine, and etoposide (TEE) for localized, high-risk, prostate cancer, RTOG 9902. The 2010 ASCO Annual Meeting. Chicago, IL; 2010.
-
(2010)
The 2010 ASCO Annual Meeting
-
-
Sandler, H.M.1
Hunt, D.2
Sartor, A.O.3
-
33
-
-
75949124984
-
Treatment strategies for high-risk locally advanced prostate cancer
-
S.A. Rosenthal, and H.M. Sandler Treatment strategies for high-risk locally advanced prostate cancer Nat Rev Urol 7 2010 31 38
-
(2010)
Nat Rev Urol
, vol.7
, pp. 31-38
-
-
Rosenthal, S.A.1
Sandler, H.M.2
-
34
-
-
0037072063
-
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial
-
DOI 10.1016/S0140-6736(02)09408-4
-
M. Bolla, L. Collette, and L. Blank Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial Lancet 360 2002 103 108 (Pubitemid 34786197)
-
(2002)
Lancet
, vol.360
, Issue.9327
, pp. 103-108
-
-
Bolla, M.1
Collette, L.2
Blank, L.3
Warde, P.4
Dubois, J.B.5
Mirimanoff, R.-O.6
Storme, G.7
Bernier, J.8
Kuten, A.9
Sternberg, C.10
Mattelaer, J.11
Torecilla, J.L.12
Pfeffer, J.R.13
Cutajar, C.L.14
Zurlo, A.15
Pierart, M.16
-
35
-
-
67149125847
-
Duration of androgen suppression in the treatment of prostate cancer
-
M. Bolla, T. de Reijke, and G. Van Tienhoven Duration of androgen suppression in the treatment of prostate cancer N Engl J Med 360 2009 2516 2527
-
(2009)
N Engl J Med
, vol.360
, pp. 2516-2527
-
-
Bolla, M.1
De Reijke, T.2
Van Tienhoven, G.3
-
36
-
-
45149105820
-
Ten-year follow-up of radiation therapy oncology group protocol 92-02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer
-
E. Horwitz, K. Bae, and G. Hanks Ten-year follow-up of radiation therapy oncology group protocol 92-02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer J Clin Oncol 26 2008 2497 2504
-
(2008)
J Clin Oncol
, vol.26
, pp. 2497-2504
-
-
Horwitz, E.1
Bae, K.2
Hanks, G.3
-
37
-
-
16344385883
-
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma - Long-term results of phase III RTOG 85-31
-
DOI 10.1016/j.ijrobp.2004.08.047
-
M. Pilepich, K. Winter, and C. Lawton Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma: Long-term results of phase III RTOG 85-31 Int J Radiat Oncol Biol Phys 61 2005 1285 1290 (Pubitemid 40470408)
-
(2005)
International Journal of Radiation Oncology Biology Physics
, vol.61
, Issue.5
, pp. 1285-1290
-
-
Pilepich, M.V.1
Winter, K.2
Lawton, C.A.3
Krisch, R.E.4
Wolkov, H.B.5
Movsas, B.6
Hug, E.B.7
Asbell, S.O.8
Grignon, D.9
-
38
-
-
65549123613
-
Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: A secondary analysis of RTOG 85-31
-
L. Souhami, K. Bae, and M. Pilepich Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: A secondary analysis of RTOG 85-31 J Clin Oncol 27 2009 2137 2143
-
(2009)
J Clin Oncol
, vol.27
, pp. 2137-2143
-
-
Souhami, L.1
Bae, K.2
Pilepich, M.3
-
39
-
-
58649103315
-
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial
-
A. Widmark, O. Klepp, and A. Solberg Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial Lancet 373 2009 301 308
-
(2009)
Lancet
, vol.373
, pp. 301-308
-
-
Widmark, A.1
Klepp, O.2
Solberg, A.3
-
40
-
-
34147174524
-
Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer
-
D.M. Kube, C.D. Savci-Heijink, and A.F. Lamblin Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer BMC Mol Biol 8 2007 25
-
(2007)
BMC Mol Biol
, vol.8
, pp. 25
-
-
Kube, D.M.1
Savci-Heijink, C.D.2
Lamblin, A.F.3
-
41
-
-
0035174607
-
Molecular genetic profiling of gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia
-
T.A. Stamey, J.A. Warrington, and M.C. Caldwell Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia J Urol 166 2001 2171 2177 (Pubitemid 33065250)
-
(2001)
Journal of Urology
, vol.166
, Issue.6
, pp. 2171-2177
-
-
Stamey, T.A.1
Warrington, J.A.2
Caldwell, M.C.3
Chen, Z.4
Fan, Z.5
Mahadevappa, M.6
McNeal, J.E.7
Nolley, R.8
Zhang, Z.9
-
42
-
-
33845884027
-
Integrative molecular concept modeling of prostate cancer progression
-
DOI 10.1038/ng1935, PII NG1935
-
S.A. Tomlins, R. Mehra, and D.R. Rhodes Integrative molecular concept modeling of prostate cancer progression Nat Genet 39 2007 41 51 (Pubitemid 46026500)
-
(2007)
Nature Genetics
, vol.39
, Issue.1
, pp. 41-51
-
-
Tomlins, S.A.1
Mehra, R.2
Rhodes, D.R.3
Cao, X.4
Wang, L.5
Dhanasekaran, S.M.6
Kalyana-Sundaram, S.7
Wei, J.T.8
Rubin, M.A.9
Pienta, K.J.10
Shah, R.B.11
Chinnaiyan, A.M.12
-
43
-
-
33746602208
-
A molecular correlate to the Gleason grading system for prostate adenocarcinoma
-
DOI 10.1073/pnas.0603678103
-
L. True, I. Coleman, and S. Hawley A molecular correlate to the Gleason grading system for prostate adenocarcinoma Proc Natl Acad Sci U S A 103 2006 10991 10996 (Pubitemid 44148406)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.29
, pp. 10991-10996
-
-
True, L.1
Coleman, I.2
Hawley, S.3
Huang, C.-Y.4
Gifford, D.5
Coleman, R.6
Beer, T.M.7
Gelmann, E.8
Datta, M.9
Mostaghel, E.10
Knudsen, B.11
Lange, P.12
Vessella, R.13
Lin, D.14
Hood, L.15
Nelson, P.S.16
-
44
-
-
9144251970
-
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
-
DOI 10.1073/pnas.0304146101
-
J. Lapointe, C. Li, and J.P. Higgins Gene expression profiling identifies clinically relevant subtypes of prostate cancer Proc Natl Acad Sci U S A 101 2004 811 816 (Pubitemid 38121040)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.3
, pp. 811-816
-
-
Lapointe, J.1
Li, C.2
Higgins, J.P.3
Van De Rijn, M.4
Bair, E.5
Montgomery, K.6
Ferrari, M.7
Egevad, L.8
Rayford, W.9
Bergerheim, U.10
Ekman, P.11
DeMarzo, A.M.12
Tibshiran, R.13
Botstein, D.14
Brown, P.O.15
Brooks, J.D.16
Pollack, J.R.17
-
45
-
-
77954255681
-
Integrative genomic profiling of human prostate cancer
-
Taylor BS, Schultz N, Hieronymus H, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell;18:11-22.
-
Cancer Cell
, vol.18
, pp. 11-22
-
-
Taylor, B.S.1
Schultz, N.2
Hieronymus, H.3
-
46
-
-
0030913315
-
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi- institutional update
-
A. Partin, M. Kattan, and E. Subong Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update JAMA 277 1997 1445 1451 (Pubitemid 27208886)
-
(1997)
Journal of the American Medical Association
, vol.277
, Issue.18
, pp. 1445-1451
-
-
Partin, A.W.1
Kattan, M.W.2
Subong, E.N.P.3
Walsh, P.C.4
Wojno, K.J.5
Oesterling, J.E.6
Scardino, P.T.7
Pearson, J.D.8
-
47
-
-
18744371597
-
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy
-
DOI 10.1097/01.ju.0000158155.33890.e7
-
M. Cooperberg, D. Pasta, and E. Elkin The University of California, San Francisco Cancer of the Prostate Risk Assessment Score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy J Urol 173 2005 1938 1942 (Pubitemid 40675216)
-
(2005)
Journal of Urology
, vol.173
, Issue.6
, pp. 1938-1942
-
-
Cooperberg, M.R.1
Pasta, D.J.2
Elkin, E.P.3
Litwin, M.S.4
Latini, D.M.5
Duchane, J.6
Carroll, P.R.7
-
48
-
-
0032950295
-
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
-
M. Kattan, T. Wheeler, and P. Scardino Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer J Clin Oncol 17 1999 1499 1507 (Pubitemid 29220858)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.5
, pp. 1499-1507
-
-
Kattan, M.W.1
Wheeler, T.M.2
Scardino, P.T.3
-
49
-
-
0034287457
-
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer
-
M. Kattan, M. Zelefsky, and P. Kupelian Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer J Clin Oncol 18 2000 3352 3359
-
(2000)
J Clin Oncol
, vol.18
, pp. 3352-3359
-
-
Kattan, M.1
Zelefsky, M.2
Kupelian, P.3
-
50
-
-
27244432751
-
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
-
A. Stephenson, P. Scardino, and J. Eastham Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Clin Oncol 23 2005 7005 7012
-
(2005)
J Clin Oncol
, vol.23
, pp. 7005-7012
-
-
Stephenson, A.1
Scardino, P.2
Eastham, J.3
|